A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT07347600 · RECRUITING
Trial details
- NCT number
- NCT07347600
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-21
- Primary completion
- 2028-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.